American Journal of Medical Quality is a pivotal publication in the field of healthcare quality and medical policy, published by Lippincott Williams & Wilkins. Since its inception in 1992, the journal has become a critical resource for researchers, practitioners, and students dedicated to improving patient care and health systems through evidence-based practices. With a current impact factor that reflects its significance in the arena of medicine and health policy, the journal falls within the Q3 category in both Health Policy and Medicine (Miscellaneous) as of 2023, ranking 253rd out of 636 in general medicine according to Scopus metrics. This underscores its relevance and prominence among peers. The journal's scope encompasses a diverse range of topics related to quality improvement initiatives, healthcare delivery systems, and policy analysis, making it an essential read for anyone invested in advancing medical quality standards and practices. While it is not an open-access journal, the content is meticulously curated to enrich the academic discourse and inform best practices in medical quality. With an ongoing commitment to addressing contemporary challenges in healthcare, American Journal of Medical Quality serves as an influential platform for advancing the knowledge and implementation of quality initiatives in medical settings.

Journal of Patient Safety and Risk Management, published by SAGE Publications Ltd, stands as a vital resource for the exploration and discourse surrounding safety and risk in healthcare environments. Established in 2018 and continuing through 2024, this journal delivers a rich repository of knowledge aimed at improving patient safety protocols and mitigating risks within healthcare systems. With an ISSN of 2516-0435 and an E-ISSN of 2516-0443, the journal is indexed in several categories with a notable performance in Health Policy and Health (social science), rated in Q3, while also addressing Leadership and Management in Q4. Despite the absence of an open access model, the journal provides a platform for researchers, healthcare professionals, and students to stay informed about the latest developments and evidence-based practices within the dynamically evolving landscape of patient safety. Given its Scopus rankings, which include a percentile of 46th in Health (social science) and 36th in Health Policy, the journal is positioned as a credible and impactful publication for those dedicated to enhancing patient care through robust risk management strategies.

Current Anesthesiology Reports is a prominent journal published by Springer Nature, dedicated to advancing the field of anesthesiology and pain medicine. With a focus on the latest clinical and research developments, this journal serves as a vital resource for researchers, clinicians, and students alike. As of 2023, it holds a respectable Q2 quartile ranking in its category, highlighting its impact and relevance within the discipline, while also ranking 59th out of 136 in Scopus, placing it in the 56th percentile for anesthesiology and pain medicine. The journal is indexed with the E-ISSN 2167-6275 and offers an open-access model that enhances visibility and accessibility of knowledge across the global medical community. Spanning research from 2013 to 2024, Current Anesthesiology Reports aims to contribute significantly to the understanding and practice of anesthesiology, reflecting the rapidly evolving landscape of the discipline.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, published by Oxford University Press, stands as a pivotal resource in the domains of Health Policy, Medicine, and Public Health. With an ISSN of 1353-4505 and an E-ISSN of 1464-3677, this journal has been a cornerstone for quality assessment in healthcare since its inception in 1989, evolving through to 2024. Holding a respected position in the academic community, it is classified in the Q2 category across multiple fields including Health Policy and Environmental Health, reflecting its significant impact as evidenced by its Scopus rankings (Rank #74/310 in Health Policy, Percentile 76th). Though it operates under a subscription model, the journal aims to disseminate pioneering research aimed at improving healthcare quality globally, providing insights that are invaluable for researchers, practitioners, and policymakers alike. With a commitment to enhancing public health landscapes, the journal continues to influence practices and outcomes in a rapidly changing health environment.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

ANESTHESIOLOGY, the premier journal in the field of anesthesiology and pain medicine, is published by Lippincott Williams & Wilkins and holds a prestigious Q1 category ranking as of 2023. With a rich history dating back to 1945, this journal serves as a vital resource for the dissemination of cutting-edge research, expert reviews, and clinical practice guidelines aimed at improving patient care and safety in anesthesia. With a remarkable impact factor and an esteemed ranking of 5 out of 136 in the category of medicine, it showcases work from leading researchers in the field, contributing to a 96th percentile Scopus rank. Although it does not offer open access, ANESTHESIOLOGY provides numerous subscription options that ensure comprehensive access to pivotal findings and advancements that shape modern anesthetic practice. This journal is indispensable for anesthesiologists, clinicians, and researchers dedicated to the innovation and refinement of anesthetic techniques, pain management, and perioperative care.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

The Joint Commission Journal on Quality and Patient Safety is a leading publication in the field of health care quality and patient safety, under the esteemed auspices of Academic Press Inc Elsevier Science. With an impact factor reflecting its rigorous peer-review process and scholarly reputation, this journal aims to disseminate cutting-edge research, innovative practices, and effective strategies that enhance patient safety and healthcare delivery, making it an essential resource for researchers, professionals, and students alike. Operating without Open Access, the journal stands out with its impressive rankings in various Scopus categories, notably #4 in Nursing & Pediatrics and #10 in Nursing Leadership & Management, evidencing its significant impact in these fields. Since its inception in 2005, the journal has become a cornerstone for advancing knowledge and improving practices in healthcare settings, continuing to contribute to the dialogue on patient outcomes and quality improvement through 2024 and beyond. For practitioners and scholars dedicated to the advancement of healthcare standards, the Joint Commission Journal on Quality and Patient Safety remains a vital source of information and inspiration.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.